Reduced crystallization inhibition by urine from men with nephrolithiasis

被引:47
作者
Asplin, JR [1 ]
Parks, JH [1 ]
Chen, MS [1 ]
Lieske, JC [1 ]
Toback, FG [1 ]
Pillay, SN [1 ]
Nakagawa, Y [1 ]
Coe, FL [1 ]
机构
[1] Univ Chicago, Renal Sect, Dept Med, Chicago, IL 60637 USA
关键词
renal stones; calcium oxalate; upper limit of metastability; crystal growth;
D O I
10.1046/j.1523-1755.1999.00682.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Human urine is known to inhibit growth, aggregation, nucleation, and cell adhesion of calcium oxalate monohydrate (COM) crystals, the main solid phase of human kidney stones. This study tests the hypothesis that low levels of inhibition are present in men with calcium oxalate stones and could therefore promote stone production. Methods. In 17 stone-forming men and 17 normal men that were matched in age to within five years, we studied the inhibition by dialyzed urine proteins of COM growth, aggregation, and binding to cultured BSC-1 renal cells, as well as whole urine upper limits of metastability (ULM) for COM and calcium phosphate (CaP) in relationship to the corresponding supersaturation (SS). Results. Compared with normals, patient urine showed reduced COM growth inhibition and reduced ULM in relationship to SS. When individual defects were considered, 15 of the 17 patients were abnormal in one or more inhibition measurements. ULM and growth inhibition defects frequently coexisted. Conclusions. Reduced COM growth and CaP and CaOx ULM values in relationship to SS are a characteristic of male stone formers. Both defects could promote stones by facilitating crystal nucleation and growth. Abnormal inhibition may be a very important cause of human nephrolithiasis.
引用
收藏
页码:1505 / 1516
页数:12
相关论文
共 46 条
  • [1] Dependence of upper limit of metastability on supersaturation in nephrolithiasis
    Asplin, JR
    Parks, JH
    Coe, FL
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (06) : 1602 - 1608
  • [2] Contribution of human uropontin to inhibition of calcium oxalate crystallization
    Asplin, JR
    Arsenault, D
    Parks, JH
    Coe, FL
    Hoyer, JR
    [J]. KIDNEY INTERNATIONAL, 1998, 53 (01) : 194 - 199
  • [3] Relationship between supersaturation and crystal inhibition in hypercalciuric rats
    Asplin, JR
    Bushinsky, DA
    Singharetnam, W
    Riordon, D
    Parks, JH
    Coe, FL
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 640 - 645
  • [4] CHARACTERIZATION OF URONIC ACID-RICH INHIBITOR OF CALCIUM-OXALATE CRYSTALLIZATION ISOLATED FROM RAT URINE
    ATMANI, F
    KHAN, SR
    [J]. UROLOGICAL RESEARCH, 1995, 23 (02): : 95 - 101
  • [5] TREATED AND UNTREATED RECURRENT CALCIUM NEPHROLITHIASIS IN PATIENTS WITH IDIOPATHIC HYPERCALCIURIA, HYPERURICOSURIA, OR NO METABOLIC DISORDER
    COE, FL
    [J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (04) : 404 - 410
  • [6] COE FL, 1980, MINER ELECTROL METAB, V3, P268
  • [7] MEDICAL PROGRESS - THE PATHOGENESIS AND TREATMENT OF KIDNEY-STONES
    COE, FL
    PARKS, JH
    ASPLIN, JR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) : 1141 - 1152
  • [8] New insights into the pathophysiology and treatment of nephrolithiasis: New research venues
    Coe, FL
    Parks, JH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (04) : 522 - 533
  • [9] Urinary kidney stone inhibitors. What is the news?
    Dussol, B
    Berland, Y
    [J]. UROLOGIA INTERNATIONALIS, 1998, 60 (02) : 69 - 73
  • [10] THE INFLUENCE OF SERUM AND SERUM-PROTEINS ON CALCIUM-OXALATE CRYSTAL-GROWTH AND AGGREGATION
    EDYVANE, KA
    RYALL, RL
    MARSHALL, VR
    [J]. CLINICA CHIMICA ACTA, 1986, 157 (01) : 81 - 87